Table 2.
Baseline characteristics of patients with essential hypertension stratified by TRIB3 genotype.
| Variable |
TRIB3 |
P-value | |
|---|---|---|---|
| AA (n) | AG+GG (n) | ||
| Age, year | 57.0 ± 8.4(243) | 56.5 ± 8.6(125) | 0.524 |
| BMI, kg/m2 | 25.2 ± 3.0(242) | 25.1 ± 3.6(125) | 0.723 |
| HR, bpm | 75.2 ± 7.5(243) | 75.1 ± 7.3(125) | 0.781 |
| SBP, mm Hg | 149.3 ± 10.3(243) | 151.2 ± 10.5(125) | 0.485 |
| DBP, mm Hg | 98.0 ± 4.3(243) | 98.3 ± 4.8(125) | 0.485 |
| MAP, mm Hg | 115.1 ± 5.3(243) | 115.9 ± 5.6(125) | 0.388 |
| PP, mm Hg | 51.3 ± 9.3(243) | 52.8 ± 9.7(125) | 0.100 |
| ALT, umol/L | 31.5 ± 17.3(212) | 31.8 ± 27.7(101) | 0.336 |
| BUN, mmol/L | 5.2 ± 1.2(222) | 6.5 ± 9.3(109) | 0.471 |
| UCr, mmol/L | 79.8 ± 16.6(237) | 79.1 ± 17.3(122) | 0.610 |
| UA, mmol/L | 320.4 ± 80.5(180) | 328.1 ± 89.6(82) | 0.246 |
| FBG, mmol/L | 5.2 ± 0.98(210) | 5.4 ± 1.2(105) | 0.739 |
| TG, mmol/ | 1.78 ± 1.6(236) | 2.33 ± 1.3(120) | 0.653 |
| CHO, mmol/L | 5.1 ± 1.0(237) | 5.4 ± 1.3(121) | 0.101 |
| HDL, μmol/L | 1.4 ± 0.3(221) | 1.4 ± 0.3(111) | 0.740 |
| LDL, umol/L | 3.4 ± 1.1(144) | 3.6 ± 1.0(78) | 0.374 |
Data expressed as mean ± SD. BMI indicates body mass index; HR, heart rate; SBP, systolic blood pressure; DBP, diastolic blood pressure; PP, pulse pressure; MAP, mean arterial pressure; ALT, alanine aminotransferase; BUN, blood urea nitrogen; UCr, urine creatinine; UA, uric acid; FBG, fasting blood-glucose; TG, triglyceride; CHO, cholesterol; HDL, high-density lipoprotein; LDL, low density lipoprotein.